Pharming Group N.V.
At a glance
Most recent filing on August 13, 2026 — an open-market purchase by Breidenbach A. on Aug 4, 2026.
Over the past 12 months: 1 open-market purchase and 2 open-market sales.
We hold 242 visible filings, going back to October 13, 2008.
Insider trades
What is a MAR filing?5 of 242 shown
Some of these filings come from the AFM register of board members and supervisory directors (art. 5:48 Wft). The AFM board-member register gives no transaction type; we derive it from the number of shares and the price.
- Breidenbach A. Chief Business Officer€45,500Open-market buy
- Bernal I. Chief People Officer€138,875Open-market sale
- Sullivan E. Board or supervisory board member38,583 sharesOther
- Pykett M. Board or supervisory board member38,583 sharesOther
- Meijs, van der J. Board or supervisory board member38,583 sharesOther
Short positions
All short positionsNet short positions of 0.5% or more in Pharming Group N.V. that are open today, as the regulator publishes them. Together they come to 4.85% of the shares. Positions below 0.5% are not published, so the real total can be higher.
6 open positions, together 4.85%. The holders and their history are part of the subscription.
Source: Autoriteit Financiële Markten (AFM), register of net short positions, as published on November 9, 2026.
The insider score is a rank of the most recent scored buy, not a forecast. How it is calculated is in the methodology. Source: the Dutch AFM register (MAR art. 19).